1-(4-benzhydrylpiperazin-1-yl)-3,3-diphenylpropan-1-one

1-(4-benzhydrylpiperazin-1-yl)-3,3-diphenylpropan-1-one
Trade Name
Orphan Indication Management of postherpetic neuralgia
USA Market Approval USA
USA Designation Date 2013-09-26 00:00:00
Sponsor Zalicus Pharmaceuticals Ltd.;245 First Street;Cambridge, Massachusetts, 02142